Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Ontology highlight
ABSTRACT: Background: Although endometrial cancer risk differs among white and black women, few data on its associations with exogenous hormone use in the latter group are available. Studies have reported lower endometrial cancer risk among users of oral contraceptives (OCs), but higher risk among users of estrogen-only female menopausal hormones (FMHs). Evidence for the risk among estrogen plus progestin FMHs users is equivocal.Methods: We followed 47,555 Black Women's Health Study participants with an intact uterus from 1995 through 2013. Data on exogenous hormone use, covariates, and endometrial cancer were obtained biennially. Self-reported incident cases of endometrial cancer were confirmed by medical records or cancer registries whenever possible. We estimated incidence rate rati
SUBMITTER: Sponholtz TR
PROVIDER: S-EPMC5991910 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA